Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Cholangiocarcinoma · Intrahepatic Cholangiocarcinoma · Extrahepatic Cholangiocarcinoma · Gallbladder Carcinoma · Biliary Tract Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
Contact: Study coordinator (Zhen J Peng, Phd) · Zhen-Peng@beijing-biotech.com · +86 13076790039

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Cancer, Metastatic · Cancer · Cancer of Pancreas

Abroad (travel likely)Recruiting

Birmingham, United States · Mobile, United States

Investigation of Predictive Biomarkers in Patients With Advanced BTC Treated With Lenvatinib Plus Pembrolizumab

Biliary Tract Cancer · Cholangiocarcinoma

Abroad (travel likely)Recruiting

Seongnam-si, South Korea

Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Patients With Taxans-resistant Pancreatic Adenocarcinoma, Cholangiocarcinoma, Lung Cancer, Gastric Cancer, Esophageal Carcinoma, or Breast Cancer

Pancreatic Adenocarcinoma · Cholangiocarcinoma · Lung Cancer

Abroad (travel likely)RecruitingPHASE2

Wuhan, China

Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma

Cholangiocarcinoma

Abroad (travel likely)RecruitingPHASE2

Chengdu, China